Composite

Part:BBa_K1462730:Design

Designed by: zhanru Chen   Group: iGEM14_SCUT   (2014-10-14)

GAL1+GBD+SH3+SH3+PDZ+ADH1


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BamHI site found at 615
    Illegal BamHI site found at 648
    Illegal BamHI site found at 820
    Illegal BamHI site found at 1029
    Illegal BamHI site found at 1238
    Illegal BamHI site found at 1561
    Illegal XhoI site found at 801
    Illegal XhoI site found at 1010
    Illegal XhoI site found at 1219
    Illegal XhoI site found at 1542
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal AgeI site found at 150
  • 1000
    COMPATIBLE WITH RFC[1000]


Design Notes

Scaffold protein, without Tom22, is a control group, #GBD: #SH3: #PDZ, 1:2:1. Without location, this part can fix the PRK, RuBisCO, CA to a limited space to increases the efficiency of interaction. In this way, We want to compare the effect of physicochemical property of Outer Membrane.


Source

The GBD,SH3,PDZ domain are synthesis from Genewiz. GAL1 and ADH1 is from the plate of IGEM.

References

[1] John E Dueber, Gabriel C Wu, G Reza Malmirchegini, et al.Synthetic protein scaffolds provide modular control over metabolic flux.Nat Biotechnol. 2009 Aug;27(8):753-9.
[2] Schultz, J. et al. Specific interactions between the syntrophin PDZ domain and voltage-gated sodium channels. Nat Struct Biol 5, 19-24 (1998).
[3] Kim, A.S., Kakalis, L.T., Abdul-Manan, N., Liu, G.A. & Rosen, M.K. Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature 404, 151-158 (2000).
[4] Wu, X. et al. Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk. Structure 3, 215-226 (1995).
[5] Dueber, J.E., Yeh, B.J., Chak, K. & Lim, W.A. Reprogramming control of an allosteric signaling switch through modular recombination. Science 301, 1904-1908 (2003).